BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 24.11 USD -2.74% Market Closed
Market Cap: 4.5B USD
Have any thoughts about
BridgeBio Pharma Inc?
Write Note

BridgeBio Pharma Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BridgeBio Pharma Inc
Accounts Payable Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
BridgeBio Pharma Inc
NASDAQ:BBIO
Accounts Payable
$13.4m
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Payable
$30.5B
CAGR 3-Years
12%
CAGR 5-Years
20%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Payable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accounts Payable
$18.9B
CAGR 3-Years
153%
CAGR 5-Years
80%
CAGR 10-Years
35%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Payable
$3.6B
CAGR 3-Years
205%
CAGR 5-Years
108%
CAGR 10-Years
58%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Payable
$497.3m
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
27%

See Also

What is BridgeBio Pharma Inc's Accounts Payable?
Accounts Payable
13.4m USD

Based on the financial report for Sep 30, 2024, BridgeBio Pharma Inc's Accounts Payable amounts to 13.4m USD.

What is BridgeBio Pharma Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
5%

Over the last year, the Accounts Payable growth was 197%. The average annual Accounts Payable growth rates for BridgeBio Pharma Inc have been 4% over the past three years , 5% over the past five years .

Back to Top